Woofun AI reports that Sam Altman has deployed capital across approximately 400 active startups, creating a complex investment web where at least 10 entities maintain direct business partnerships or ongoing discussions with OpenAI. This intricate network has drawn the attention of the US House Oversight Committee, which launched an investigation into potential conflicts of interest as OpenAI prepares for its initial public offering.

Concurrently, several state attorneys general have formally requested that the SEC intervene to scrutinize these overlapping financial interests. Despite holding no direct equity in OpenAI, which currently carries a valuation of $852 billion, Altman's personal wealth trajectory is inextricably linked to the performance of these affiliated ventures. The Wall Street Journal analysis reveals that many of the more than 80 identified investment projects originated during his tenure at Y Combinator, with a heavy concentration in software, biotechnology, and energy sectors central to the AI revolution.

The financial implications of these cross-border investments are starkly illustrated by specific case studies within the portfolio. Evidence presented during the lawsuit filed by Elon Musk against OpenAI indicated that Altman's shares in the anti-aging startup Retro Biosciences were valued at $258 million as of December last year. In the semiconductor sector, Altman invested in chip manufacturer Cerebras nearly 10 years ago, a position that saw dramatic appreciation following a recent chip purchase agreement between Cerebras and OpenAI. This strategic alignment facilitated Cerebras' listing, and subsequent to the IPO, the value of Altman's holdings in the company increased by more than six times compared to the valuation recorded in December last year. These transactions highlight how Altman's early-stage bets are often amplified by later-stage commercial agreements involving the AI giant he leads.

Bret Taylor, serving as OpenAI's chairman, has asserted that Altman maintains transparency regarding his involvement in external corporate affairs, noting that OpenAI has implemented careful protocols to manage potential conflicts.

However, the fusion startup Helion represents a significant flashpoint where these protocols faced intense internal scrutiny. Although Helion claims to be nearing commercial power generation, it has historically withheld public disclosure of its research results. Altman's active promotion of a partnership between OpenAI and Helion generated substantial controversy within the organization. In 2025, the Japanese investment firm SoftBank committed capital to OpenAI, after which Altman successfully persuaded SoftBank to also invest in Helion. A few months later, Altman urged OpenAI to allocate approximately $500 million directly to Helion, a proposal that many employees found suspicious and troubling, leading to the board's ultimate rejection of the investment.

The resolution of the Helion saga involved a series of strategic maneuvers that further complicated the narrative of conflict. In March 2026, OpenAI and Helion signed a revised agreement, and in the same month, Altman resigned from his position as Helion's chairman, citing the need to prioritize future cooperation with OpenAI as his primary reason. OpenAI subsequently stated that the board deemed this agreement to be in the "best interests" of the company. By June 2026, Helion announced the completion of a new financing round valued at $15.5 billion, with Thrive Capital, a strategic investor in OpenAI, participating as the lead investor. According to sources familiar with the matter, Altman's stake in Helion increased in value by at least half during this period, reaching a valuation of at least $4.1 billion.

Woofun AI data shows that these valuation shifts correlate directly with the timing of OpenAI's strategic decisions and board-level approvals regarding Helion.

Parallel to the Helion developments, Tools for Humanity, the entity behind World Coin, has re-entered the spotlight following an internal investigation scandal. Amid a backdrop of collapsing cryptocurrency prices, intensifying global regulatory scrutiny, and significant business contraction accompanied by layoffs, the company initiated two separate investigations led by external law firms. One inquiry focuses on the alleged improper use of funds by senior management, while the other examines purported violations in the company's operations within Thailand. These internal probes occur as OpenAI itself faces criticism regarding its multi-trillion-dollar contracts with major cloud and chip manufacturers. The scope of these agreements includes a $500 billion partnership with NVIDIA, a $300 billion agreement with AMD, a $300 billion collaboration with Oracle, and a deal worth over $22 billion with data center company CoreWeave. The sheer scale of these commitments underscores the massive capital flows surrounding the AI ecosystem in which Altman operates.

The cumulative effect of these diverse investments has propelled Altman to new heights on the global wealth ladder. According to the Forbes list of billionaires, Sam Altman currently ranks 1,251st globally with a net worth of approximately $3.4 billion. His portfolio extends beyond AI-specific ventures to include stakes in well-known technology companies such as Stripe and Reddit. The velocity of this wealth accumulation is particularly notable when viewed through a historical lens. In April 2024, Altman's ranking on the Forbes list was only 2,692nd; two years later, his net worth had risen by more than 1,400 places. This meteoric rise, occurring alongside regulatory probes and internal governance debates, suggests that the intersection of personal investment and corporate strategy remains a volatile yet lucrative frontier for industry leaders. The convergence of these factors marks a critical juncture where personal financial gain and institutional fiduciary duty are being tested under unprecedented public and regulatory pressure.